Winton Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.2M | Buy |
132,440
+72,440
| +121% | +$20M | 0.95% | 8 |
|
|
2026
Q1 | $17.7M | Sell |
60,000
-82
| -0.1% | -$24.4K | 0.62% | 17 |
|
|
2025
Q4 | $16.4M | Buy |
60,082
+82
| +0.1% | +$22.3K | 0.57% | 18 |
|
|
2025
Q3 | $16.2M | Sell |
60,000
-172
| -0.3% | -$46.8K | 0.61% | 20 |
|
|
2025
Q2 | $16.6M | Sell |
60,172
-15,933
| -21% | -$4.33M | 0.85% | 12 |
|
|
2025
Q1 | $20.2M | Buy |
76,105
+15,565
| +26% | +$3.84M | 1.23% | 4 |
|
|
2024
Q4 | $14.1M | Sell |
60,540
-503
| -0.8% | -$116K | 0.93% | 17 |
|
|
2024
Q3 | $13.5M | Buy |
61,043
+1,043
| +2% | +$216K | 0.94% | 19 |
|
|
2024
Q2 | $11.8M | Hold |
60,000
| – | – | 0.8% | 38 |
|
|
2024
Q1 | $12.9M | Sell |
60,000
-6,332
| -10% | -$1.33M | 0.91% | 20 |
|
|
2023
Q4 | $14M | Buy |
66,332
+6,332
| +11% | +$1.35M | 1.02% | 18 |
|
|
2023
Q3 | $12M | Sell |
60,000
-150
| -0.2% | -$29.8K | 0.99% | 14 |
|
|
2023
Q2 | $11.1M | Sell |
60,150
-33,879
| -36% | -$6.26M | 0.93% | 16 |
|
|
2023
Q1 | $18M | Buy |
94,029
+3,696
| +4% | +$668K | 1.1% | 5 |
|
|
2022
Q4 | $15.2M | Buy |
90,333
+29,568
| +49% | +$5.14M | 1% | 7 |
|
|
2022
Q3 | $10.8M | Buy |
60,765
+615
| +1% | +$122K | 0.7% | 15 |
|
|
2022
Q2 | $12.3M | Sell |
60,150
-8,719
| -13% | -$1.85M | 0.65% | 13 |
|
|
2022
Q1 | $16.4M | Sell |
68,869
-2,993
| -4% | -$703K | 0.86% | 10 |
|
|
2021
Q4 | $16.4M | Buy |
71,862
+11,778
| +20% | +$2.59M | 0.99% | 3 |
|
|
2021
Q3 | $11.6M | Buy |
60,084
+23
| +0% | +$4.66K | 0.65% | 15 |
|
|
2021
Q2 | $12.8M | Buy |
60,061
+24
| +0% | +$5.07K | 0.69% | 14 |
|
|
2021
Q1 | $12.3M | Sell |
60,037
-93
| -0.2% | -$18.3K | 0.7% | 12 |
|
|
2020
Q4 | $10.9M | Sell |
60,130
-182
| -0.3% | -$31K | 0.79% | 10 |
|
|
2020
Q3 | $10.1M | Sell |
60,312
-38
| -0.1% | -$6.4K | 0.33% | 24 |
|
|
2020
Q2 | $9.81M | Sell |
60,350
-21,635
| -26% | -$3.88M | 0.25% | 43 |
|
|
2020
Q1 | $14.2M | Sell |
81,985
-46,341
| -36% | -$9.22M | 0.37% | 21 |
|
|
2019
Q4 | $25.8M | Sell |
128,326
-49,206
| -28% | -$10.1M | 0.36% | 19 |
|
|
2019
Q3 | $37.5M | Buy |
177,532
+101,610
| +134% | +$21.2M | 0.44% | 59 |
|
|
2019
Q2 | $14.7M | Buy |
75,922
+55
| +0.1% | +$10.1K | 0.29% | 139 |
|
|
2019
Q1 | $12.5M | Sell |
75,867
-7,935
| -9% | -$1.4M | 0.25% | 146 |
|
|
2018
Q4 | $15.8M | Buy |
83,802
+15,010
| +22% | +$2.77M | 0.34% | 102 |
|
|
2018
Q3 | $11.7M | Buy |
68,792
+6,714
| +11% | +$1.13M | 0.25% | 167 |
|
|
2018
Q2 | $10.2M | Buy |
62,078
+761
| +1% | +$124K | 0.26% | 127 |
|
|
2018
Q1 | $9.92M | Sell |
61,317
-1,002
| -2% | -$160K | 0.28% | 83 |
|
|
2017
Q4 | $9.1M | Sell |
62,319
-2,482
| -4% | -$353K | 0.26% | 104 |
|
|
2017
Q3 | $8.79M | Sell |
64,801
-1,530
| -2% | -$193K | 0.28% | 91 |
|
|
2017
Q2 | $8.31M | Buy |
66,331
+3,983
| +6% | +$476K | 0.24% | 127 |
|
|
2017
Q1 | $7.41M | Sell |
62,348
-4,401
| -7% | -$529K | 0.2% | 150 |
|
|
2016
Q4 | $7.7M | Sell |
66,749
-455
| -0.7% | -$50.6K | 0.25% | 122 |
|
|
2016
Q3 | $7.02M | Sell |
67,204
-27,371
| -29% | -$2.86M | 0.12% | 216 |
|
|
2016
Q2 | $9.21M | Sell |
94,575
-96,301
| -50% | -$9.1M | 0.15% | 195 |
|
|
2016
Q1 | $18.3M | Sell |
190,876
-132,625
| -41% | -$12.1M | 0.2% | 185 |
|
|
2015
Q4 | $29.3M | Sell |
323,501
-105,609
| -25% | -$9.94M | 0.26% | 158 |
|
|
2015
Q3 | $39.8M | Buy |
429,110
+181,397
| +73% | +$17.2M | 0.31% | 120 |
|
|
2015
Q2 | $23.1M | Buy |
247,713
+187,713
| +313% | +$17.5M | 0.21% | 175 |
|
|
2015
Q1 | $5.68M | Hold |
60,000
| – | – | 0.05% | 340 |
|
|
2014
Q4 | $5.32M | Sell |
60,000
-55,997
| -48% | -$4.75M | 0.07% | 324 |
|
|
2014
Q3 | $9.28M | Sell |
115,997
-92,285
| -44% | -$6.95M | 0.07% | 333 |
|
|
2014
Q2 | $14.8M | Buy |
+208,282
| New | +$14.7M | 0.1% | 306 |
|
Other funds holding CME
Winton Group's CME Position: Q2 2026 in Review
Winton Group increased its CME Group (CME) stake by 121% in Q2 2026, buying an estimated $20M and bringing the position to 132,440 shares worth $29.2M. The position accounts for 0.95% of the portfolio, ranked #8.
Winton Group first reported a position in CME in Q2 2014 and has held it in 49 quarters since. The position peaked at $39.8M in Q3 2015. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Winton Group held 132,440 shares of CME Group worth $29.2M as of Q2 2026.
- Winton Group bought 72,440 CME Group shares in Q2 2026, an estimated $20M.
- CME Group made up 0.95% of Winton Group's portfolio in Q2 2026, its #8 holding.
- Winton Group first reported a position in CME Group in Q2 2014 and has held it in 49 quarters since.
- Winton Group's CME Group position peaked at $39.8M in Q3 2015.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.